Search Results - "Farina, Antonietta R"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma by Tacconelli, Antonella, Farina, Antonietta R, Cappabianca, Lucia, Gulino, Alberto, Mackay, Andrew R

    Published in Future oncology (London, England) (01-10-2005)
    “…An association between elevated tyrosine kinase receptor (Trk)-A expression and better prognosis; the absence of mutation-activated TrkA oncogenes; the…”
    Get more information
    Journal Article
  5. 5
  6. 6

    TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance by Tacconelli, Antonella, Farina, Antonietta R., Cappabianca, Lucia, Gulino, Alberto, Mackay, Andrew R.

    Published in Cell cycle (Georgetown, Tex.) (01-01-2005)
    “…Nerve growth factor receptor TrkA is critical for development and maturation of central and peripheral nervous systems, regulating proliferation,…”
    Get full text
    Journal Article
  7. 7

    TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma by Tacconelli, Antonella, Farina, Antonietta R., Cappabianca, Lucia, DeSantis, Giuseppina, Tessitore, Alessandra, Vetuschi, Antonella, Sferra, Roberta, Rucci, Nadia, Argenti, Beatrice, Screpanti, Isabella, Gulino, Alberto, Mackay, Andrew R.

    Published in Cancer cell (01-10-2004)
    “…We identify a novel alternative TrkA splice variant, TrkAIII, with deletion of exons 6, 7, and 9 and functional extracellular IG-C1 and N-glycosylation…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain by Farina, Antonietta R., Cappabianca, Lucia, Di Ianni, Natalia, Ruggeri, Pierdomenico, Ragone, Marzia, Merolle, Stefania, Gulino, Alberto, Mackay, Andrew R.

    Published in FEBS letters (30-07-2012)
    “…► We report the inhibitory effect of plasmin in the presence of Alendronate upon proMMP-9. ► Alendronate promotes non-reversible plasmin-mediated MMP-9…”
    Get full text
    Journal Article
  10. 10

    TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH-SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype by Mackay, Andrew R., Ianni, Giulia, Ragone, Marzia, Ruggeri, Pierdomenico, Cappabianca, Lucia, Di Ianni, Natalia, Farina, Antonietta R., Gulino, Alberto

    Published in BioMed research international (01-01-2013)
    “…The alternative TrkAIII splice variant is expressed by advanced stage human neuroblastomas (NBs) and exhibits oncogenic activity in NB models. In the present…”
    Get full text
    Journal Article
  11. 11

    TrkAIII expression in the thymus by Tacconelli, Antonella, Farina, Antonietta R, Cappabianca, Lucia, Cea, Gesilia, Panella, Sonia, Chioda, Antonella, Gallo, Rita, Cinque, Benedetta, Sferra, Roberta, Vetuschi, Antonella, Campese, Antonio Francesco, Screpanti, Isabella, Gulino, Alberto, Mackay, Andrew R

    Published in Journal of neuroimmunology (01-02-2007)
    “…Abstract The alternative TrkAIII splice variant is expressed by murine and human thymus. Alternative TrkAIII splicing predominates in postembryonic day E13…”
    Get full text
    Journal Article
  12. 12

    Thioredoxin inhibits microvascular endothelial capillary tubule formation by Farina, Antonietta R, Tacconelli, Antonella, Cappabianca, Lucia, DeSantis, Giuseppina, Gulino, Alberto, Mackay, Andrew R

    Published in Experimental cell research (10-12-2003)
    “…Thioredoxin (Trx) inhibited human HMEC-1 dermal microvascular endothelial cell capillary tubule forming capacity in a Matrigel based assay in vitro. Inhibition…”
    Get full text
    Journal Article
  13. 13

    Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate by FARINA, A. R, TACCONELLI, A, TETI, A, GULINO, A, MACKAY, A. R

    Published in Cancer research (Chicago, Ill.) (15-07-1998)
    “…The degradation of tissue inhibitor of metalloproteinase (TIMP)-free matrix metalloproteinase (MMP)-2 to proteolytically inactive fragments by plasmin was…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Inhibition of human MDA‐MB‐231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen by Farina, Antonietta R., Tacconelli, Antonella, Cappabianca, Lucia, Gulino, Alberto, Mackay, Andrew R

    Published in European journal of biochemistry (01-09-2002)
    “…Matrix metalloproteinase (MMP)‐3 inhibited human MDA‐MB‐231 breast cancer cell invasion through reconstituted basement membrane in vitro. Inhibition of…”
    Get full text
    Journal Article
  16. 16

    Transcriptional Modulation of the Human Intercellular Adhesion Molecule Gene I (ICAM-1) by Retinoic Acid in Melanoma Cells by Cilenti, Lucia, Toniato, Elena, Ruggiero, Paolo, Fusco, Carlo, Farina, Antonietta R., Tiberio, Antonella, Hayday, Adrian C., Gulino, Alberto, Frati, Luigi, Martinotti, Stefano

    Published in Experimental cell research (01-05-1995)
    “…Retinoids play an important role as differentiating agents in a variety of normal and neoplastic cells and have been reported to induce ICAM-1 levels in…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Transforming growth factor‐β1 enhances the invasiveness of human MDA‐MB‐231 breast cancer cells by up‐regulating urokinase activity by Farina, Antonietta R., Coppa, Anna, Tiberio, Antonella, Tacconelli, Antonella, Turco, Alessandra, Colletta, Gulia, Gulino, Alberto, Mackay, Andrew R.

    Published in International journal of cancer (02-03-1998)
    “…Transforming growth factor‐beta (TGFβ1) enhances human MDA‐MB‐231 breast tumour cell invasion of reconstituted basement membrane in vitro but does not inhibit…”
    Get full text
    Journal Article
  19. 19
  20. 20